Sou Hu Cai Jing·2026-01-29 19:32Group 1 - The core point of the article highlights that southbound funds have reduced their holdings in Chunli Medical (01858.HK) by 385,200 shares on January 29, with a total net reduction of 241,000 shares over the last five trading days and 3,009,300 shares over the last twenty trading days [1] - As of now, southbound funds hold 42,105,600 shares of Chunli Medical, accounting for 44.25% of the company's total issued ordinary shares [1] - Chunli Medical is primarily engaged in the research, development, production, and sales of implantable orthopedic medical devices, with key products including joint prosthetics, spinal implants, trauma products, sports medicine products, PRP products, oral products, and surgical robots [1] Group 2 - The company's joint prosthetic products cover major human joints such as hip, knee, shoulder, and elbow, and its products are sold in both domestic and international markets [1]